Company intelligence / Profile preview

Roche

Basel, Basel-Stadt, Switzerlandgenentechoncology.com ↗

Ownership: Public · RHHBY
Employees: ~100000
Development stage: Commercial

Overview

Roche is a global leader in pharmaceuticals and diagnostics with numerous commercial products and a diverse pipeline. Recent research setbacks have led to cutting about 20% of its pipeline in recent quarters as the company refocuses on innovation.

Therapeutic areas: CardiovascularOphthalmologyImmunologyEndocrinologyOncologyNeurologyInfectious Diseases
Modalities: Small moleculesbiologicsgene therapycell therapyantibodies
Industry: Pharma

Drug pipeline

387 assets

pegylated interferon alpha

Approved

386 more assets in the full pipeline.

Request access →

Financials

Market cap: $344.7B
Total revenue: $31B
Enterprise value: $366.7B

Beyond the preview

Go deeper on Roche.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Roche.

Explore the full profile